XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,281,888 | -59.8% | 96,074 | -54.7% | 0.01% | -56.5% |
| Q2 2023 | $8,166,967 | +6.6% | 212,129 | -0.9% | 0.02% | 0.0% |
| Q1 2023 | $7,661,064 | -10.7% | 214,056 | -1.6% | 0.02% | -17.9% |
| Q4 2022 | $8,580,757 | +9.3% | 217,620 | +0.1% | 0.03% | +12.0% |
| Q3 2022 | $7,851,000 | +463.2% | 217,474 | +374.6% | 0.02% | +525.0% |
| Q2 2022 | $1,394,000 | +33.4% | 45,823 | +34.0% | 0.00% | +100.0% |
| Q1 2022 | $1,045,000 | – | 34,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |